How to Reduce an Enlarged Uterus: Causes & Treatments

An enlarged uterus almost always stems from one of two conditions: fibroids (benign muscular tumors) or adenomyosis (endometrial tissue growing into the uterine wall). Both are common, and both respond to a range of treatments spanning medications, minimally invasive procedures, and surgery. The right approach depends on symptoms, the degree of enlargement, and whether you want to preserve fertility. Encouragingly, for many people the uterus will shrink on its own after menopause, so the treatment timeline matters as much as the treatment itself.

Why the Uterus Enlarges in the First Place

Fibroids are far and away the leading cause. They are the most common benign tumors in people with a uterus, and they affect roughly a quarter of those of reproductive age with noticeable symptoms. These growths start from a single smooth muscle cell in the uterine wall that picks up a mutation, usually during the hormonal cycling of estrogen and progesterone that accompanies ovulation. The mutated cells and the surrounding tissue then lay down excessive amounts of structural protein, which is what gives fibroids their firm, fibrous feel and drives the uterus to expand well beyond its normal size.¹ A single fibroid can range from the size of a pea to the size of a melon, and many people have several at once.

Adenomyosis is the second major cause. Instead of a discrete tumor, the tissue that normally lines the inside of the uterus burrows into the muscular wall. The result is a diffusely swollen, boggy uterus rather than a lumpy one. Researchers still debate exactly how this happens; proposed mechanisms include microtrauma at the boundary between the uterine lining and the muscle, abnormal invasion of endometrial cells, and hormonal signaling that goes awry.² Fibroids and adenomyosis can coexist, which complicates both diagnosis and treatment planning.

Pregnancy is, of course, a physiological reason for an enlarged uterus, and it resolves through involution after delivery. How quickly the uterus shrinks back to its pre-pregnancy size varies considerably from person to person, though most of the reduction happens in the first few weeks postpartum.³

Symptoms That Prompt People to Seek Treatment

Many enlarged uteruses are found incidentally during a routine exam or imaging done for another reason. When symptoms do appear, the most common is heavy menstrual bleeding, which can lead to anemia and fatigue over time. Fibroids are a well-documented cause of this pattern, and they can also produce pelvic pain, pressure, and difficulty conceiving.⁴

When the uterus grows large enough, it presses on neighboring structures. Urinary frequency, urgency, and waking up at night to urinate can all result from direct pressure on the bladder.⁵ In extreme cases, a massively enlarged uterus can displace bowel loops and compress major blood vessels.⁶ These pressure symptoms often drive the decision to pursue treatment even in the absence of heavy bleeding.

Getting the Right Diagnosis

Transvaginal ultrasound is the usual first step, and it works well for identifying fibroids and estimating uterine size. MRI, however, gives a more detailed picture and is more accurate at distinguishing between fibroids and adenomyosis. In a systematic review covering over 2,300 women, MRI was somewhat more sensitive and notably more specific than ultrasound for diagnosing adenomyosis.⁷ In roughly one in eight patients being evaluated for fibroid treatment, ultrasound did not correctly count or locate the fibroids compared with MRI.⁸

This distinction matters because it changes what treatment will work best. Fibroids are discrete masses that can be targeted individually, while adenomyosis is diffuse and woven into the muscle. Your doctor might start with ultrasound and add MRI if the picture is unclear or if a procedure like embolization or ablation is being considered.

Medications That Can Shrink the Uterus

Drug therapy is generally the first line if you want to avoid a procedure or buy time before one. Several classes of medications have solid evidence behind them for fibroids, and some are used for adenomyosis as well.

GnRH Agonists and Antagonists

These drugs work by suppressing estrogen and progesterone, the hormones that fuel fibroid growth. GnRH agonists (like leuprolide) have been used for decades as a preoperative tool to shrink fibroids before surgery. In one randomized trial, GnRH agonist treatment before hysterectomy reduced uterine bulk by about 20%, making the procedure easier and less invasive.⁹

The newer GnRH antagonists (like relugolix, combined with low-dose hormones to limit menopausal side effects) offer a more convenient oral option. A meta-analysis of five trials found a moderate reduction in fibroid volume compared with placebo.¹⁰ The main limitation of any GnRH-based treatment is that fibroids tend to regrow once you stop taking the drug, so these medications are often used either as a bridge to surgery or as ongoing therapy if side effects are manageable.

Selective Progesterone Receptor Modulators

These drugs block progesterone’s action at the uterus without suppressing estrogen system-wide, which means fewer menopausal symptoms like hot flashes. Ulipristal acetate and mifepristone have both shown consistent ability to reduce fibroid size, control bleeding, and improve quality of life.¹¹ Cochrane review data support that these drugs shrink fibroids and the uterus overall, and they often stop menstrual bleeding altogether during treatment.¹² Availability varies by country, and some agents in this class have had their development paused over liver safety concerns, so this is an area where you need to discuss the current options with your provider.

Levonorgestrel-Releasing Intrauterine Device

For adenomyosis specifically, the hormonal IUD (often known by the brand name Mirena) is a widely used treatment. It does not eliminate the condition, but it delivers progesterone directly to the uterine lining, which can thin it dramatically and reduce both bleeding and uterine size. One study found that the average uterine volume dropped significantly in the first two years after insertion, though the shrinkage effect plateaued by year three.¹³ A practical concern is that in adenomyosis with a very large uterus, the device is more likely to be expelled spontaneously.¹⁴ Some clinicians use a course of GnRH agonist first to shrink the uterus and then insert the IUD, which helps it stay in place. That combined approach has been shown to keep uterine size below pre-treatment levels at a year of follow-up.¹⁵

Minimally Invasive Procedures

When medications are not enough or you prefer a more definitive solution without major surgery, several image-guided procedures can shrink fibroids (and in some cases adenomyosis) while preserving the uterus.

Uterine Artery Embolization

Uterine artery embolization (UAE) is performed by an interventional radiologist who threads a catheter through a blood vessel in the groin or wrist and injects tiny particles into the arteries feeding the uterus. With their blood supply cut off, fibroids shrink over the following months. Literature reviews report mean fibroid shrinkage ranging from about 50 to 78%, with heavy bleeding improving in 80 to 93% of cases.¹⁶ A large cohort study found that most of the uterine volume decrease happens in the first three months, with continued fibroid shrinkage between three and six months.¹⁷ Interestingly, larger fibroids tend to show a greater percentage of volume reduction than smaller ones.¹⁸

UAE is generally a one-night hospital stay with a recovery measured in days rather than weeks. The main drawback is post-procedure cramping, which can be intense for the first day or two, and the fact that its effect on future fertility is less clear than that of myomectomy.

Focused Ultrasound (HIFU)

High-intensity focused ultrasound uses heat generated by concentrated sound waves to destroy fibroid tissue without any incision. In one center’s experience, the average fibroid volume shrank by about 68% at six months and 75% at a year.¹⁹ Another prospective study using a portable HIFU system found progressive shrinkage, with about a 45% volume reduction at five months.²⁰ The treatment is attractive because it requires no anesthesia in many setups and has minimal recovery time. It works best for fibroids that are not too numerous and not in tricky locations near the bowel or spine.

For people hoping to conceive afterward, HIFU has encouraging early data. One institution reported 71 pregnancies in 55 patients after treatment, with over 80% conceived naturally and about 61% resulting in successful deliveries.²¹ Those numbers are promising, though the spontaneous abortion rate was also notable, and more data are needed before HIFU can be considered a standard fertility-preserving option.

Transcervical Radiofrequency Ablation

This newer approach involves threading a device through the cervix and using radiofrequency energy to heat and destroy fibroid tissue from the inside. The Sonata system, one of the best-studied devices, has shown average fibroid volume reductions around 68% in clinical trials, with significant improvement in symptom scores.²² Long-term follow-up confirms that fibroids continue to shrink after the procedure.²³ The procedure is done as an outpatient, and because it goes through the natural cervical opening, there is no abdominal incision.

Radiofrequency ablation has also been explored for adenomyosis, where a case report and small review found uterine volume reductions exceeding 50% and adenomyosis volume reductions above 90%, with a lower rate of side effects and shorter treatment times compared with HIFU.²⁴ This is early-stage evidence, but it signals that ablation technology may expand beyond fibroids.

Surgical Options

Surgery enters the picture when symptoms are severe, other treatments have failed, or the uterus is simply too large for less invasive approaches. The main surgical choices fall along a spectrum of how much tissue is removed.

Myomectomy removes the fibroids while leaving the uterus intact. It is the standard surgical option for people who want to preserve fertility. Myomectomy can be performed through an abdominal incision, laparoscopically, or hysteroscopically depending on the size and location of the fibroids. The limitation is that new fibroids can develop afterward, since the underlying tendency to form them remains. Myomectomy can also cause adhesions in the abdominal cavity, which sometimes impair fertility rather than help it.²⁵

For adenomyosis, an analogous procedure called adenomyomectomy involves cutting out the areas of abnormal tissue from the uterine wall and then carefully reconstructing the muscle. Because adenomyosis does not have neat borders the way a fibroid does, this surgery is technically more challenging. One prospective study of over 100 patients with severe adenomyosis found that the procedure reduced pain and heavy bleeding, and about 30% of those who tried to conceive afterward achieved a clinical pregnancy.²⁶ Surgeons have developed specialized reconstruction techniques, like triple-flap methods, designed to strengthen the uterine wall and prevent rupture in future pregnancies.²⁷

Hysterectomy, removal of the uterus itself, is the definitive treatment. It eliminates fibroids, adenomyosis, and the symptoms they cause with no possibility of recurrence. Satisfaction rates are high, and for people who have completed their families and are dealing with debilitating symptoms, it often represents a significant improvement in quality of life. Uterus-sparing hysteroscopic approaches (which treat fibroids or abnormal bleeding through the cervix without removing the uterus) have also shown strong quality-of-life outcomes in direct comparisons with hysterectomy.²⁸

Do Diet and Supplements Help?

You will find no shortage of online advice about “shrinking fibroids naturally,” and most of it outpaces the evidence. Two areas, though, have genuine research behind them, even if the science is still early.

Green tea extract, specifically a compound called EGCG, showed striking results in a pilot trial: after four months of daily supplementation, fibroid volume dropped by an average of about a third, while the placebo group actually saw their fibroids grow.²⁹ That is a single small trial, so it would be unwise to treat green tea pills as a substitute for proven therapies. But the finding is biologically plausible; EGCG inhibits cell growth and the buildup of the structural proteins that make fibroids enlarge.³⁰

Vitamin D is the other candidate. Lab studies have found that fibroid cells have reduced vitamin D receptors, and treating those cells with vitamin D slows their growth and reduces the structural-protein production that drives enlargement.³¹ Clinical evidence also supports a link between adequate vitamin D levels and lower fibroid incidence and growth.³⁰ Neither supplement is a replacement for medical treatment, but correcting a vitamin D deficiency and incorporating green tea are low-risk steps that align with the available data.

The Menopause Factor

Fibroids are hormone-dependent growths, and when estrogen and progesterone levels decline at menopause, most fibroids begin to shrink on their own. This natural regression is a real phenomenon, though it is not universal; some fibroids persist after menopause, and the effects of hormone replacement therapy on fibroid regrowth remain inconclusive. If your symptoms are tolerable and menopause is on the near horizon, watchful waiting is a reasonable strategy. Many people find their fibroids become asymptomatic without any intervention once their hormonal environment changes.

When Rapid Growth or Unusual Features Raise a Red Flag

The vast majority of enlarged uteruses are benign, but distinguishing a fibroid from a uterine sarcoma (a rare cancer) matters. Some clinical features should prompt closer evaluation. In a study comparing women with sarcoma to those with fibroids, the sarcoma group tended to be older and more likely to be postmenopausal. They were also more likely to have a single mass rather than many, a subserosal location, and a history of documented rapid growth.³² On MRI, features like irregular borders, heterogeneous enhancement, signs of hemorrhage, and restricted water diffusion increase suspicion for sarcoma.³³

No imaging technique can diagnose sarcoma with certainty before surgery, so tissue sampling or surgical removal is ultimately needed when suspicion is high. What this means practically is that a postmenopausal person with a rapidly enlarging uterine mass should not assume it is “just a fibroid” and should push for thorough workup. For premenopausal people with typical-appearing, slowly growing fibroids, the risk of sarcoma is extremely low, and the differential diagnosis is more likely to be adenomyosis, a transient uterine contraction caught on imaging, or an ovarian mass mimicking a uterine one.³⁴